Associated Papers
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
37304756 (PubMed )
Supplement: zcad025_supplemental_files.zip › Supplementary_Table_2.xlsx › BVs
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F et al.
Cell Death and Differentiation, 2021
33257846 (PubMed )
Supplement: 41418_2020_672_MOESM1_ESM.pdf
Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.
Diakite B et al.
Bmc Medical Genetics, 2020
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients.
Koczkowska M et al.
Cancers, 2018
30441849 (PubMed )
Supplement: cancers-10-00442-s001.pdf
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.
Leroy B et al.
Cancer Research, 2017
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
Sagne C et al.
Cell Death & Disease, 2013
Intron 3 sixteen base pairs duplication polymorphism of p53 contributes to breast cancer susceptibility: evidence from meta-analysis.
Wu D et al.
Plos One, 2013
A quadruplex tetra-primer ARMS-PCR method for the simultaneous detection of TP53 Arg72Pro, IVS3 16bp Del/Ins and IVS6+62A>G, and NQO1 C609T polymorphisms.
Lajin B et al.
Gene, 2012
Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
Ashton KA et al.
Gynecologic Oncology, 2009
High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling.
Bastien R et al.
Human Mutation, 2008
Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women.
Singh V et al.
Annals of Epidemiology, 2008
Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation Analysis.
Hu Z et al.
Journal of Cancer Epidemiology, 2008
Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
Garcia-Closas M et al.
Bmc Cancer, 2007
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A et al.
Oncogene, 2007
Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India.
De Chaudhuri S et al.
Mutation Research, 2006
Role of p53 gene polymorphism and bladder cancer predisposition in northern India.
Srivastava P et al.
Cancer Biomarkers : Section a of Disease Markers, 0
Select a paper to view details